Fig. 2From: Real-world analysis of different intracranial radiation therapies in non-small cell lung cancer patients with 1–4 brain metastasesComparison of cumulative incidence of OS (a), iPFS (b), DBF-FS (c) of patients with or without neurological symptomsBack to article page